ARTICLE | Company News
InforSense, National Cancer Institute deal
September 5, 2005 7:00 AM UTC
The National Cancer Institute's Core Genotyping Facility will use InforSense's InforSense KDE analytics technology for a five-year term for high-throughput analyst of genetic data related to cancer. ...